Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Intratumoral CpG, Local Radiation, and Oral Ibrutinib Combine to Produce Effective in Situ Vaccination in Patients with Low-Grade B-Cell Lymphoma

Tanaya Shree, MDPhDBA, Michael S. Khodadoust, MD PhD, Debra K. Czerwinski, BA, Matthew J. Frank, MD PhD, Sara Beygi, MD, Steven R. Long, MD, Brock Martin, MD, Ronald Levy, MD

Blood (2020) 136 (Supplement 1): 48.

https://doi.org/10.1182/blood-2020-141377

Published: 2020

Journal Articles

Single Cell Analysis of Serial Lymphoma Biopsies Reveals Dynamic Immune Modulation and Predictors of Response in Patients Undergoing in Situ Vaccination

Tanaya Shree, MDPhDBA, Sarah Haebe, MD, Anuja Sathe, PhD, Grady Day, Debra K. Czerwinski, BA, HoJoon Lee, PhD, Susan Grimes, BSc, Steven R. Long, MD, Brock Martin, MD, Hanlee Ji, MD, Ronald Levy, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-141672

Published: 2020

Journal Articles

Dynamic Immune Modulation Seen By Single Cell RNA-Sequencing of Serial Lymphoma Biopsies in Patients Undergoing in Situ Vaccination

Tanaya Shree, MD PhD, Sarah Haebe, MD, Anuja Sathe, PhD, Grady Day, HoJoon Lee, PhD, Debra K. Czerwinski, BA, Susan Grimes, BSc, Hanlee Ji, MD, Ronald Levy, MD

Blood (2019) 134 (Supplement_1): 1479.

https://doi.org/10.1182/blood-2019-131684

Published: 2019

Journal Articles

A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma

Tanaya Shree, MD PhD, Michael S. Khodadoust, MD PhD, Debra K. Czerwinski, BA, Matthew J. Frank, MD PhD, Wan X. Hong, MD, Rachel Greenstein, Steven R. Long, MD, Brock Martin, MD, Ronald Levy, MD

Blood (2019) 134 (Supplement_1): 2825.

https://doi.org/10.1182/blood-2019-129661

Published: 2019

Journal Articles

Site to Site Comparison of Follicular Lymphoma Biopsies By Single Cell RNA Sequencing

Sarah Haebe, MD, Tanaya Shree, MDPhDBA, Anuja Sathe, PhD, Grady Day, HoJoon Lee, PhD, Debra K. Czerwinski, BA, Susan Grimes, BSc, Hanlee Ji, MD, Ronald Levy, MD

Blood (2019) 134 (Supplement_1): 297.

https://doi.org/10.1182/blood-2019-129445

Published: 2019

Journal Articles

Single Cell RNA Sequencing of Serial Tumor and Blood Biopsies from Lymphoma Patients on an in Situ Vaccination Clinical Trial

Tanaya Shree, MD PhD BA, Anuja Sathe, PhD, Debra K. Czerwinski, BA, Steven R. Long, MD, Hanlee Ji, MD, Ronald Levy, MD

Blood (2018) 132 (Supplement 1): 4107.

https://doi.org/10.1182/blood-2018-99-119925

Published: 2018

Journal Articles

Intratumoral Injection of CpG-ODN Plus Systemic Ibrutinib Induces an Anti-Tumor Immune Response Affecting T Cell Subsets in the Microenvironment of Both Injected and Non-Injected Tumor Sites in Patients with Low-Grade Lymphoma

Debra K. Czerwinski, BA, Matthew J. Frank, MD PhD, Tanaya Shree, MD PhD BA, Michael S Khodadoust, MD PhD, Steven R. Long, MD, Ronald Levy, MD

Blood (2018) 132 (Supplement 1): 1612.

https://doi.org/10.1182/blood-2018-99-119931

Published: 2018

Journal Articles

In Situ Vaccination with Cpg and Anti-OX40 Antibody: Preclinical Optimization for Clinical Translation

Idit Sagiv Barfi, PhD, Debra K. Czerwinski, BA, Tanaya Shree, MD PhD BA, Ronald Levy, MD

Blood (2018) 132 (Supplement 1): 2943.

https://doi.org/10.1182/blood-2018-99-117872

Published: 2018

Journal Articles

Single-Cell Analysis of the Immune Microenvironment in Follicular Lymphoma: Cell Surface Protein Vs. Intracellular mRNA

Debra K. Czerwinski, BA, Ronald Levy, MD

Blood (2017) 130 (Supplement 1): 5144.

https://doi.org/10.1182/blood.V130.Suppl_1.5144.5144

Published: 2017

Journal Articles

Eradication of Systemic Lymphoma By Local Immunotherapy

Idit Sagiv Barfi, PhD, Debra K. Czerwinski, BA, Ronald Levy, MD

Blood (2017) 130 (Supplement 1): 113.

https://doi.org/10.1182/blood.V130.Suppl_1.113.113

Published: 2017

Journal Articles

The Percentage of Tumor-Infiltrating T Cells Is Not Correlated with Overall Survival in Follicular B-Cell Lymphomas.

Wei Yun Ai, MD, PhD, Debra K. Czerwinski, BA, Rob Tibshirani, PhD, Sandra J. Horning, MD, Ronald Levy, MD

Blood (2004) 104 (11): 3262.

https://doi.org/10.1182/blood.V104.11.3262.3262

Published: 2004

NARROW

Intratumoral CpG, Local Radiation, and Oral Ibrutinib Combine to Produce Effective in Situ Vaccination in Patients with Low-Grade B-Cell Lymphoma

Single Cell Analysis of Serial Lymphoma Biopsies Reveals Dynamic Immune Modulation and Predictors of Response in Patients Undergoing in Situ Vaccination

Dynamic Immune Modulation Seen By Single Cell RNA-Sequencing of Serial Lymphoma Biopsies in Patients Undergoing in Situ Vaccination

A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma

Site to Site Comparison of Follicular Lymphoma Biopsies By Single Cell RNA Sequencing

Single Cell RNA Sequencing of Serial Tumor and Blood Biopsies from Lymphoma Patients on an in Situ Vaccination Clinical Trial

Intratumoral Injection of CpG-ODN Plus Systemic Ibrutinib Induces an Anti-Tumor Immune Response Affecting T Cell Subsets in the Microenvironment of Both Injected and Non-Injected Tumor Sites in Patients with Low-Grade Lymphoma

In Situ Vaccination with Cpg and Anti-OX40 Antibody: Preclinical Optimization for Clinical Translation

Single-Cell Analysis of the Immune Microenvironment in Follicular Lymphoma: Cell Surface Protein Vs. Intracellular mRNA

Eradication of Systemic Lymphoma By Local Immunotherapy

The Percentage of Tumor-Infiltrating T Cells Is Not Correlated with Overall Survival in Follicular B-Cell Lymphomas.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only